State Street
RBOT

State Street’s Vicarious Surgical RBOT Stock Holding History

State Street’s Portfolio RBOT Stock Details RBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-39,367
Closed -$356K – 4387
2024
Q1 		$356K Buy
39,367
+422
+1% +$5.03K ﹤0.01% 3731
2023
Q4 		$428K Sell
38,945
-905
-2% -$10.1K ﹤0.01% 3675
2023
Q3 		$706K Buy
39,850
+756
+2% +$27.5K ﹤0.01% 3601
2023
Q2 		$2.15M Buy
39,094
+10,943
+39% +$697K ﹤0.01% 3381
2023
Q1 		$1.92M Buy
28,151
+34
+0.1% +$2.64K ﹤0.01% 3355
2022
Q4 		$1.7M Buy
28,117
+89
+0.3% +$8.27K ﹤0.01% 3425
2022
Q3 		$2.82M Buy
28,028
+3,430
+14% +$400K ﹤0.01% 3310
2022
Q2 		$2.17M Buy
24,598
+20,063
+442% +$2.45M ﹤0.01% 3449
2022
Q1 		$688K Buy
4,535
+3,828
+541% +$712K ﹤0.01% 3927
2021
Q4 		$225K Buy
+707
New +$249K ﹤0.01% 4298

Other funds holding RBOT

VS
VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return
DP
DDD Partners Bellevue, Washington $1.45B AUM 9.14% 1-Year Est. Return
MAMHA
MY.Alpha Management HK Advisors Hong Kong $246M AUM 73.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AMH
Aspex Management (HK) Central, Hong Kong $6.9B AUM 28.37% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street's RBOT Position: Q2 2024 in Review

State Street sold out of Vicarious Surgical (RBOT) in Q2 2024, closing a stake of 39,367 shares — an estimated $356K sold.

State Street first reported a position in RBOT in Q4 2021 and held it in 10 quarters. The position peaked at $2.82M in Q3 2022. 38 funds tracked by Wall St. Rank hold RBOT as of Q2 2024.

  • State Street reported no remaining Vicarious Surgical position as of Q2 2024 after selling out during the quarter.
  • State Street sold 39,367 Vicarious Surgical shares in Q2 2024, an estimated $356K.
  • State Street first reported a position in Vicarious Surgical in Q4 2021 and held it in 10 quarters.
  • State Street's Vicarious Surgical position peaked at $2.82M in Q3 2022.
  • 38 funds tracked by Wall St. Rank held Vicarious Surgical as of Q2 2024.

Based on State Street's 13F filing for Q2 2024, filed 14 Aug 2024.